Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Quest Diagnostics › T. Rowe Price Associates, Inc. cut its DGX stake below 5% (4.9%) Fund moves
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Jun 30, 2026
Reporting period Not applicable
Filed with the SEC Aug 14, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0000080255-26-000528
Data quality Verified: identifiers matched exactly The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Mar 10, 2025 Congress Disclosed sale of DGX — reported range $15,001 - $50,000 Oct 28, 2025 Federal contract · $2.7M obligated Department of Veterans Affairs awarded Quest Diagnostics: $2.75M obligated to date Oct 30, 2025 Congress · 1 person Members of Congress: 1 purchase, 1 sale Mar 24, 2026 Federal contract · $6.6M obligated Department of Veterans Affairs awarded Quest Diagnostics: $6.57M obligated to date Mar 27, 2026 Congress Disclosed purchase of DGX — reported range $1,001 - $15,000 Mar 30, 2026 Congress Disclosed purchase of DGX — reported range $1,001 - $15,000 Apr 1, 2026 Federal contract · $3.1M obligated Department of Veterans Affairs awarded Quest Diagnostics: $3.12M obligated to date May 1, 2026 Federal contract · $2.6M obligated Department of Veterans Affairs awarded Quest Diagnostics: $2.6M obligated to date May 6, 2026 Company filing · Form 8-K · Material agreement Signed an important agreement Jun 1, 2026 Insider CEO sold ~$1.94M of DGX shares in the open market Jun 4, 2026 Insider · Their largest sale since 2024 Officer sold ~$1.63M of DGX shares in the open market What came next Jul 23, 2026 Company filing · Form 8-K · Results Reported its results Jul 28, 2026 Insider Officer sold ~$376K of DGX shares in the open market Aug 14, 2026 5% stake T. Rowe Price Associates, Inc. reported a passive stake (13G) of 4.9% Aug 28, 2026 Insider · 1 person Insiders: 3 sales (~$5.5M)